PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | |diabetes |
| Sentences | 69 |
| PubMedID- 24667697 | The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25885947 | High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. |
| PubMedID- 21478462 | The association of a shorter duration of diabetes with liver disease has been described before. |
| PubMedID- 23671610 | We aim to investigate the relationships that fatty pancreas and nonalcoholic fatty liver disease (nafld) have with prediabetes and diabetes in a chinese population. |
| PubMedID- 20625647 | Objective: to evaluate the frequency of non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (dm2) and to describe its risk factors. |
| PubMedID- 24625618 | Er stress has been closely linked to various human diseases including inflammatory diseases, cardiovascular diseases, diabetes, and all types of human liver diseases . |
| PubMedID- 24485856 | As for the management of diabetes in patients with liver disease, lifestyle modification plays an important role. |
| PubMedID- 26390278 | diabetes is associated with liver disease progression and increased hepatocellular carcinoma risk, but factors associated with diabetes in patients with chronic hepatitis b virus (hbv) infection in north america are unknown. |
| PubMedID- 22927782 | The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. |
| PubMedID- 24952996 | Established fatty liver disease is associated with diabetes, which itself induces enteric neuron damage. |
| PubMedID- 25790917 | Conclusion: our investigations show that in fatty liver disease in combination with obesity and diabetes, the hepatocyte-protecting organelle peroxisome is altered. |
| PubMedID- 21435130 | The aim of this case-control study is to assess the efficacy and safety of dipeptidyl peptidase-4 inhibitor (sitagliptin) for type 2 diabetes mellitus (t2dm) with chronic liver disease caused by hcv. |
| PubMedID- 22913901 | Managing diabetes in patients with chronic liver disease. |
| PubMedID- 26573192 | Objective: to investigate the effect of body mass index (bmi) on new-onset non-alcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25303488 | High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels. |
| PubMedID- 23869321 | Quoted that “non-alcoholic fatty liver disease is associated with type 2 diabetes and the metabolic syndrome.” the retrospective review is done. |
| PubMedID- 26381272 | Comparative efficacy of anti-diabetic agents on nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized and non-randomized studies. |
| PubMedID- 25120322 | Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease. |
| PubMedID- 24402015 | Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease. |
| PubMedID- 22787177 | Despite higher susceptibility to nonalcoholic fatty liver disease in patients with type 2 diabetes, a similar alt and ast elevation was observed in a type 1 diabetes study of ly2605541 (17). |
| PubMedID- 23578506 | Objective: to explore the liver disease spectrum in patients with type 2 diabetes (t2dm) and the risk factors of non-alcoholic fatty liver disease (nafld). |
| PubMedID- 24669954 | Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease. |
| PubMedID- 24919218 | Advancement of researches on association of non-alcoholic fatty liver disease with type 2 diabetes mellitus. |
| PubMedID- 21601719 | Risk factors for development of liver disease for patients with bipolar disorder: diabetes (or=1.40), hiv (or=3.66), sud (or=2.68), alcohol use disorder (or=3.22) and bipolar disorder (or=2.27). |
| PubMedID- 23332087 | This critical review of the published work aims to highlight the most recent basic and clinical data underlying the development of type 2 diabetes, in those with non-alcoholic fatty liver disease. |
| PubMedID- 21932714 | diabetes is associated with chronic liver disease and liver cancer in the adult population of puerto rico. |
| PubMedID- 22024083 | Sitagliptin as a novel treatment agent for non-alcoholic fatty liver disease patients with type 2 diabetes mellitus. |
| PubMedID- 21664213 | Due to the worldwide surge in obesity and type 2 diabetes, the increased incidence of nonalcoholic fatty liver disease (nafld) is a major concern for the public health. |
| PubMedID- 23991421 | It has been found that among men with diabetes, the risk of chronic nonalcoholic liver disease and hcc is doubled . |
| PubMedID- 24912965 | The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey. |
| PubMedID- 22156706 | We examined the prevalence of advanced liver disease in people with type 2 diabetes and analysed the effectiveness of liver function tests (lfts) as a screening tool. |
| PubMedID- 24717062 | *non-significant elixhauser comorbidity measures across the frequency groups included peripheral vascular disease, hypertension, neurological disorders, diabetes with complications, liver disease, peptic ulcer disease, acquired immunodeficiency syndrome, lymphoma, solid tumor without metastasis, coagulopathy, fluid and electrolyte disorders, anemia, and alcohol abuse. |
| PubMedID- 25961500 | Interferon gamma-induced protein 10 is associated with insulin resistance and incident diabetes in patients with nonalcoholic fatty liver disease. |
| PubMedID- 26454513 | Clinically significant chronic liver disease in people with type 2 diabetes: the edinburgh type 2 diabetes study. |
| PubMedID- 22025861 | Our study revealed that silymarin has good effect in the restoration of liver function and also established efficacy in controlling blood glucose level in diabetes patients with liver diseases. |
| PubMedID- 26315331 | Background: liver disease in diabetes is common and is frequently the result of hepatic steatosis. |
| PubMedID- 20736249 | In this study, we examined serum 1,5-ag levels in chronic liver disease (cld) patients with and without diabetes mellitus. |
| PubMedID- 24550655 | Bpa has also been associated with chronic disease in humans including cardiovascular disease, diabetes, and serum markers of liver disease (14). |
| PubMedID- 21596453 | Serum fgf21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hscrp levels independently. |
| PubMedID- 23433228 | Previous studies reported associations of diabetes with chronic liver disease and various types of cancer . |
| PubMedID- 23954219 | Objective: to investigate the relationship between the resistin intronic +299g/a polymorphism and nonalcoholic fatty liver disease (nafld) in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 25841911 | Majority of cases of hcc are due to chronic viral hepatitis b and c infections; however non-alcoholic fatty liver disease, associated with obesity and diabetes emerges as an important risk factor for hcc, in particular in the developed countries. |
| PubMedID- 26573193 | Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 21329534 | Treatment of diabetes in patients with chronic liver disease can theoretically improve survival. |
| PubMedID- 24587848 | The association between hcv and diabetes with liver disease severity was explored by hui et al. |
| PubMedID- 21850244 | Conclusions: elevated ggt and gpt-values as well as estimates of fatty liver disease are significantly associated with pre-diabetes and diabetes and thus very useful first indicators of a disturbed glucose metabolism. |
| PubMedID- 26005676 | Fatty liver disease in diabetes mellitus. |
| PubMedID- 24071688 | Objective: to observe the effect of metformin on the expression of sirt1 and ucp2 in rat liver of type 2 diabetes mellitus (t2dm) with nonalcoholic fatty liver disease (nafld), and discuss the pathogenesis of t2dm with nafld, and the treatment with and possible mechanism of metformin. |
| PubMedID- 23226654 | Introduction: non-alcoholic fatty liver disease (nafld) is associated with type 2 diabetes (t2dm) and the metabolic syndrome, and can progress to chronic liver disease. |
Page: 1 2